Cargando…

Apatinib in Advanced Gastric Cancer: A Doubtful Step Forward

Detalles Bibliográficos
Autores principales:	Fornaro, Lorenzo, Vasile, Enrico, Falcone, Alfredo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Clinical Oncology 2016
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477932/ https://www.ncbi.nlm.nih.gov/pubmed/27528730 http://dx.doi.org/10.1200/JCO.2016.68.6931

Ejemplares similares

A Doubting Thomas
por: Loggins, L. L.
Publicado: (1903)

Is Treatment-Emergent Toxicity a Biomarker of Efficacy of Apatinib in Gastric Cancer?
por: Lee, Hyo Jin, et al.
Publicado: (2016)

Problematic Analysis and Inadequate Toxicity Data in Phase III Apatinib Trial in Gastric Cancer
por: Zhang, Sheng
Publicado: (2016)

Climate change and health—Stopping the merchants of doubt
por: Kentros, Peter A.
Publicado: (2020)

Doubt at the core: Unspoken vaccine hesitancy among healthcare workers
por: Heyerdahl, Leonardo W., et al.
Publicado: (2021)

Medical service fees – a key step forward
por: Jiao, Wei-Ping
Publicado: (2019)

Comment on: ‘Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort'
por: Vivaldi, Caterina, et al.
Publicado: (2016)

Finally, a step forward in nomenclature of subchondral nonneoplastic bone lesions
por: Postma, William Fulton, et al.
Publicado: (2020)

Role of Baseline Computed-Tomography-Evaluated Body Composition in Predicting Outcome and Toxicity from First-Line Therapy in Advanced Gastric Cancer Patients
por: Catanese, Silvia, et al.
Publicado: (2021)

What doubts, concerns and fears about COVID-19 emerged during the first wave of the pandemic?
por: Boeger, Vinicius Silveira, et al.
Publicado: (2022)

Apatinib combined with S-1 as second-line therapy in advanced gastric cancer
por: Qiu, Zhi-Yuan, et al.
Publicado: (2021)

European Heart and Rhythm Association guidelines on new oral anticoagulants: A bold step forward
por: Sehgal, Vishal, et al.
Publicado: (2014)

A step forward parameter for the effects of transcatheter aortic valve implantation: transmural dispersion of repolarization
por: Tezcan, Mehmet, et al.
Publicado: (2015)

Beyond the Guidelines: The Grey Zones of the Management of Gastric Cancer. Consensus Statements from the Gastric Cancer Italian Network (GAIN)
por: Fornaro, Lorenzo, et al.
Publicado: (2021)

Efficacy and safety assessment of apatinib in patients with advanced gastric cancer: a meta-analysis
por: Chen, Jianxin, et al.
Publicado: (2018)

Efficacy and safety for Apatinib treatment in advanced gastric cancer: a real world study
por: Zhang, Yong, et al.
Publicado: (2017)

Expression of p53 as a biomarker in determining response to apatinib for advanced gastric cancer
por: Qiu, Zhiyuan, et al.
Publicado: (2023)

Doubt, a history /
por: Hecht, Jennifer Michael, 1965-
Publicado: (2004)

Concurrent apatinib and docetaxel vs apatinib monotherapy as third- or subsequent-line therapy for advanced gastric adenocarcinoma: a retrospective study
por: Lin, Haimin, et al.
Publicado: (2019)

Efficacy of the Low Dose Apatinib plus Chemotherapy on Advanced Gastric Carcinoma
por: Gao, Shen, et al.
Publicado: (2022)

Meta-Analysis of Efficacy and Safety of Karelizumab Combined with Apatinib in the Treatment of Advanced Gastric Cancer
por: Liu, Haipeng, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors in Esophageal Cancers: Are We Finally Finding the Right Path in the Mist?
por: Vivaldi, Caterina, et al.
Publicado: (2020)

Doubting darkness
Publicado: (2017)

In Faith and In Doubt
por: McGowan, Dale
Publicado: (2014)

Effectiveness and safety of low‐dose apatinib in advanced gastric cancer: A real‐world study
por: Du, Yingying, et al.
Publicado: (2020)

A Study Of Efficacy And Safety With Apatinib Or Apatinib Combined With Chemotherapy In Recurrent/advanced Ovarian Cancer Patients
por: Yang, Mi, et al.
Publicado: (2019)

Apatinib combined with PD-1 antibody for third-line or later treatment of advanced gastric cancer
por: Cui, Qingli, et al.
Publicado: (2022)

A Doubtful Witness
Publicado: (1861)

Advances on Prevention and Screening of Gynecologic Tumors: Are We Stepping Forward?
por: Giannini, Andrea, et al.
Publicado: (2022)

Neoadjuvant PD-1 Inhibitor Plus Apatinib and Chemotherapy Versus Apatinib Plus Chemotherapy in Treating Patients With Locally Advanced Gastric Cancer: A Prospective, Cohort Study
por: Wang, Chunjing, et al.
Publicado: (2023)

Concurrent apatinib and local radiation therapy for advanced gastric cancer: A case report and review of the literature
por: Zhang, Ming, et al.
Publicado: (2017)

Male mammary gland development after apatinib therapy in advanced gastric cancer: A case report
por: Hui, Yan, et al.
Publicado: (2020)

PD-1 inhibitor combined with apatinib for advanced gastric or esophagogastric junction cancer: a retrospective study
por: Wei, Qing, et al.
Publicado: (2020)

Apatinib enhances chemosensitivity of gastric cancer to paclitaxel and 5-fluorouracil
por: Xu, Zhiyuan, et al.
Publicado: (2019)

Efficacy and safety of apatinib for the treatment of AFP-producing gastric cancer
por: Li, Ningning, et al.
Publicado: (2020)

Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer
por: Del Re, Marzia, et al.
Publicado: (2017)

Gastritis – facts and doubts
por: Muszyński, Jacek, et al.
Publicado: (2016)

Doubtful Tumours of the Breast
Publicado: (1900)

The Doubtful Case of Diphtheria
Publicado: (1921)

Case of Doubtful Sex
por: Barry, Wm. James
Publicado: (1847)

Cannot write session to /tmp/vufind_sessions/sess_f3mur08vtpmvltr2ginvold3if